Boutique Venture Partners

About Boutique Venture Partners

Boutique Venture Partners is a small US venture firm with a generalist tech mandate that surfaces minimal public detail about healthcare focus, AI thesis, or check size discipline. The website (boutiquevp.com), LinkedIn, and Crunchbase pages exist but do not advertise a healthcare practice, a regulated-industry team, or stated stage criteria. For healthcare AI founders, the honest read is that this is a peripheral fund: capital that may show up in a syndicate alongside a stronger lead, not a firm to organize a round around. Plausible check sizes for a small partnership of this profile run 100K to 500K at seed, with limited follow-on capacity. Founders building horizontal AI tooling that happens to be sold into healthcare buyers, or consumer-adjacent digital health products, could open a conversation. Founders building anything regulated, clinically integrated, or requiring FDA strategy should look at firms with healthcare-native partners; Boutique offers no signal of that depth. Entry path is LinkedIn direct message to a partner with a sharp two-sentence positioning, ideally accompanied by a syndicate signal that someone credible is already leading. Do not expect technical due diligence on models or deep clinical domain pushback; expect a generalist read on team, market, and traction. If you are pre-product or pre-revenue, the bar will be team pedigree more than anything else, so lead with that.

Founder reviews

No founder reviews yet. Raised from this fund? Share your experience with other founders.
Portfolio data coming soon. Know their portfolio? Suggest an edit →
Team information coming soon. Know the partners? Suggest an edit →

Pitch / review this investor

Have you raised from Boutique Venture Partners? Founders only — share your honest experience (anonymous OK, moderated before publishing).

Share your experience
Last updated 2026-05-06. Sourced from this fund's published materials.
AI Tool Finder
AI-powered search. Results may not be comprehensive.